IRVINE, Calif.ChromaDex Corp. (CDXC) partnered with Brazilian Biosciences National Laboratory (LNBio) to evaluate its natural product libraries. The collaboration will screen natural product libraries against certain molecular targets and phenotypic assays to identify possibly patentable natural products.
"If successful, this collaboration could lead to rapid commercialization of novel natural products for food, beverage, cosmetic or pharmaceutical applications," said Kleber Gomes Franchini, director of LNBio.
"The ChromaDex catalog offers thousands of very unique phytochemical compounds primarily isolated from botanicals," said Frank Jaksch, Jr., founder and CEO of ChromaDex. "We are very excited to start this collaboration with LNBio, as this program will allow ChromaDex to extract value from the natural products library we have been developing over the past 15 years."
Earlier this year, ChromaDex granted marketing rights to 5LINX for NIAGEN.